Alnylam Pharmaceuticals, Inc.
$278.09
$4.63(-1.64%)
ALNY
Alnylam Pharmaceuticals, Inc.
$278.09
1D:
-1.6%
1Y:
-11.2%
US02043Q1076Healthcare
Chart
Key stats
52-Week Range$278.09
$273.11
$495.55
Market capitalization
$37.13BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
63.78Basic EPS (TTM)
$4.36Net income (TTM)
$577.22MRevenue (TTM)
$4.29BAvg. volume
1.13MBeta (1Y)
0.27Employees
2.23KMarket capitalization
$37.13BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
63.78Basic EPS (TTM)
$4.36Net income (TTM)
$577.22MRevenue (TTM)
$4.29BAvg. volume
1.13MBeta (1Y)
0.27Employees
2.23KScreener Quick Check
Sign in to check this stock against your screeners
Sign InRelated Stocks
$279.27
1D:
-2.0%
1Y:
-11.2%
US1255231003Healthcare
Mkt Cap
$73.88B
P/E Ratio TTM
11.8
Revenue TTM
$277.94B
Beta
0.30
Earnings TTM
$6.29B
Dividend Yield TTM
2.20%
$609.94
1D:
0.3%
1Y:
19.7%
US75886F1075Healthcare
Mkt Cap
$62.84B
P/E Ratio TTM
14.3
Revenue TTM
$14.92B
Beta
0.24
Earnings TTM
$4.42B
Dividend Yield TTM
0.60%